Brainstorm Cell Therapeutics's total assets for Q1 2025 were $3.57M, an increase of 94.92% from the previous quarter. BCLI total liabilities were $11.03M for the fiscal quarter, a 14.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.